Pharm-Olam is ready for GDPR.  Learn how GDPR impacts you and how your organization can be ready, too.

Pharm-Olam's Global Data Protection Officer, Natasa Spasic, held a 60-minute interactive session where she brought participants up to speed on GDPR, or the Global Data Protection Regulation, and what organizations needed to do to be prepared for its implementation. 

These new regulations will fundamentally change how you run your clinical trials. If your organization does not come into compliance with GDPR, you could be exposing your organization to massive fines and/or penalties from the European Union. 

  • Topics covered included: 
    • What is GDPR
    • What impact does GDPR have on your organization and on clinical trial conduct
    • What do you need to have in place to comply with the regulation
    • Are there differences in country-by-country interpretation
    • How Pharm-Olam’s Bow Tie Method was utilized to manage our compliance readiness
    • Where you turn for assistance and adaptation during transition

A recording of the webinar will be sent within a week of the webinar's conclusion on May 15, 2018.  To have your questions answered, feel welcome to email  

Register To Access Webinar recording

What To Know


All Sponsors who are currently conducting or plan to conduct clinical research in the United Kingdom and any European Union member countries.  If you collect data on European Union citizens, this regulation will directly impact your organization and clinical trials. 
The webinar was held live on May 15, 2018. To access the recording, simply fill out the form above.

The Webinar Presenters

Natasa Spasic_new.png

Natasa Spasic 

Data Protection Officer
& GDPR Compliance Certified

Pharm-Olam International

Yamin 22Mo22 Khan.jpeg

Dr. Yamin ‘Mo’ Khan

Executive Vice President,
Global Clinical Development

Pharm-Olam International